These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25748050)

  • 41. Thyroid hormone receptors promote metastasis of human hepatoma cells via regulation of TRAIL.
    Chi HC; Chen SL; Liao CJ; Liao CH; Tsai MM; Lin YH; Huang YH; Yeh CT; Wu SM; Tseng YH; Chen CY; Tsai CY; Chung IH; Chen WJ; Lin KH
    Cell Death Differ; 2012 Nov; 19(11):1802-14. PubMed ID: 22576662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.
    Yang J; Sun M; Zhang A; Lv C; De W; Wang Z
    World J Surg Oncol; 2011 Oct; 9():117. PubMed ID: 21970601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.
    Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X
    Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Short hairpin RNA silencing of vascular endothelial growth factor, telomerase reverse transcriptase, and Bcl-xl expression in human laryngeal squamous carcinoma xenografted in nude mice].
    Wang Y; Chen SM; Xiao BK; Tao ZZ
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):831-6. PubMed ID: 19159530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus.
    Zhou W; Zhu H; Chen W; Hu X; Pang X; Zhang J; Huang X; Fang B; He C
    Cancer Gene Ther; 2011 May; 18(5):336-45. PubMed ID: 21183948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of malignant melanoma by downregulation of XIAP and overexpression of TRAIL with a conditionally replicating oncolytic adenovirus.
    Li XQ; Ke XZ; Wang YM
    Asian Pac J Cancer Prev; 2012; 13(4):1471-6. PubMed ID: 22799350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
    Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X
    Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.
    Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF
    Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
    Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
    Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncolytic Adenovirus Expressing ST13 Increases Antitumor Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Against Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Ye M; Huang F; Wang S; Wang H; Mou X; Wang Y
    Hum Gene Ther; 2020 Aug; 31(15-16):891-903. PubMed ID: 32475172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL.
    Song JJ; An JY; Kwon YT; Lee YJ
    J Biol Chem; 2007 Jan; 282(1):319-28. PubMed ID: 17110373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication.
    Han Z; Joo Y; Lee J; Ko S; Xu R; Oh GH; Choi S; Hong JA; Choi HJ; Song JJ
    Exp Mol Med; 2019 Oct; 51(10):1-20. PubMed ID: 31615977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
    Lee YJ; Hwang IS; Lee YJ; Lee CH; Kim SH; Nam HS; Choi YJ; Lee SH
    J Korean Med Sci; 2014 Nov; 29(11):1464-72. PubMed ID: 25408576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of lentivirus-mediated expression of tumor necrosis factor related apoptosis-inducing ligand and shRNA against Bcl-2 on the growth of lymphoma cells.
    Zhang X; Zhao L; Chen C; Yan J; Zhou C; Yue G; Tian L; Zhang M
    Leuk Lymphoma; 2012 Apr; 53(4):710-7. PubMed ID: 21988644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer.
    Zhu W; Zhang H; Shi Y; Song M; Zhu B; Wei L
    Cancer Biol Ther; 2013 Nov; 14(11):1016-23. PubMed ID: 24025362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer.
    Zhou W; Dai S; Zhu H; Song Z; Cai Y; Lee JB; Li Z; Hu X; Fang B; He C; Huang X
    Gene Ther; 2017 Apr; 24(4):199-207. PubMed ID: 28075429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.
    Lin Y; Xu T; Teng H; Cui M
    Int J Clin Exp Pathol; 2015; 8(9):10061-71. PubMed ID: 26617713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.